Search the Newsreel

FDA Sets Jan. 6 Target Date for ImmunityBio's ANKTIVA Review

SFNC|Simmons First National Corp|Price:23.880|Chg%:+0.290

LEG Immobilien reports steady rental growth amid FFO pressure

Investing.com -- LEG Immobilien AG (ETR:LEGn) on Tuesday reported second quarter results showing continued operational strength with 3.7% like-for-like rental growth, though funds from operations remained under pressure from higher investment and interest costs. The German residential property company posted cold rents of €473.4m, …

3 Healthcare Stocks We Find Risky

3 Healthcare Stocks We Find Risky Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 16.6% over the past six months, …

Zimmer Biomet (ZBH) Q2 Earnings: What To Expect

Sei Investments Co. Has $7.88 Million Stock Position in Simmons First National Corporation $SFNC

Sei Investments Co. significantly increased its holdings in Simmons First National Corporation (NASDAQ:SFNC) by 151.6% in the first quarter, now owning 405,336 shares valued at $7.88 million. Despite Simmons First National's recent quarterly results falling slightly short of analyst expectations for EPS and revenue, …

Altimmune (ALT) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $ALT

This article provides a comprehensive overview of Altimmune's FDA-related activities for its drug pemvidutide, detailing clinical trial updates, regulatory submissions, and designations through 2026. Pemvidutide is being developed for conditions including obesity, MASH (metabolic dysfunction-associated steatohepatitis),

Bitmine Immersion (BMNP) holds $11.3B in crypto, cash and ‘moonshots’

Bitmine Immersion Technologies (BMNR) reported total holdings of $11.3 billion in crypto, cash, and "moonshot" investments as of August 2, 2026. This includes 5.8 million ETH (representing 4.8% of total supply), 209 BTC, $173 million in cash, and stakes in Beast Industries and Eightco. …

Altimmune (ALT) CFO acquires 1,753 shares via employee stock purchase plan

Altimmune, Inc. (ALT) CFO Gregory L. Weaver acquired 1,753 shares of common stock on July 31, 2026, through the company's 2019 Employee Stock Purchase Plan (ESPP). The shares were purchased at $2.414 each, representing 85% of the closing price on that day, for the …

Bronstein, Gewirtz & Grossman, LLC Encourages ImmunityBio, Inc. (IBRX) Investors to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of ImmunityBio, Inc. (NASDAQ:IBRX) securities who bought shares prior to January 19, 2026, and continue to hold them. The investigation aims to determine if ImmunityBio and its officers engaged in corporate …

Tom Lee's Bitmine Buys 10,399 ETH For $19.1 Million: Why Is BMNR Not Rallying?

Tom Lee's Bitmine Immersion (BMNR) recently purchased 10,399 ETH for $19.1 million, citing Ethereum's strong outperformance against the Nasdaq 100. Despite this significant acquisition and a substantial share buyback program, BMNR stock has not rallied, pulling back to $17.04. The company now holds 5.8 …

Tom Lee’s Bitmine Buys More Ethereum, Adds to Stock Buyback

Ethereum treasury company Bitmine Immersion Technologies said Monday it bought another 10,399 ETH, or roughly $19.5 million worth, over the past week, extending a year-long buying streak that has made it the world's largest corporate holder of Ethereum. The company said it now holds …

Estrella adds third site to EB103 lymphoma trial

Estrella Immunopharma Inc. has activated Oregon Health & Science University as the third clinical site for its STARLIGHT-1 Phase I/II trial of EB103. The trial evaluates EB103, a CD19-Redirected ARTEMIS T-cell therapy, in patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma. This expansion will …

Bitmine Immersion Technologies reports $11.3B crypto and cash holdings, 5.8M ETH and major buybacks

Bitmine Immersion Technologies (BMNR) has reported significant holdings, including $11.3 billion in crypto, cash, and marketable securities, with 5.8 million ETH. The company has also repurchased 4.5 million common shares recently, contributing to a total of 16.1 million shares bought back under a $4 …

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 5.8 Million Tokens, and Total Crypto and Total Cash Holdings of $11.3 Billion

Bitmine Immersion Technologies (BMNR) announced that its total crypto and cash holdings have reached $11.3 billion, with 5.8 million ETH tokens, representing 4.8% of the total ETH supply. The company reported that ETH outperformed the Nasdaq 100 by 2,500 basis points in July 2026, …

Altimmune Initiates PERFORMA Phase 3 Trial Of Pemvidutide In Patients With Mash

Altimmune has announced the initiation of its PERFORMA Phase 3 trial for pemvidutide. This trial focuses on evaluating the drug's efficacy in patients diagnosed with MASH (Metabolic Dysfunction-Associated Steatohepatitis). The information was released via Reuters and is available on TradingView.

Simmons Bank Trims Staff as Efficiency Push Continues

Simmons Bank has implemented staff reductions as part of a regular review of its operations aimed at improving efficiency. While the bank's director of investor and media relations confirmed "shifts in operational structures and personnel changes," specific details about the number and location of …

Research Analysts Issue Forecasts for Shimmick Q2 Earnings

Craig Hallum anticipates Shimmick Corporation (NASDAQ:SHIM) will report a Q2 2026 loss of $0.07 per share, aligning with a full-year consensus estimate of a $0.08 loss per share. The company currently holds a consensus "Hold" rating from analysts with an average price target of …

Militia Capital Management LLC Takes Position in BitMine Immersion Technologies, Inc. $BMNR

Militia Capital Management LLC has acquired a new position in BitMine Immersion Technologies, Inc. (BMNR) during the first quarter, purchasing 82,098 shares valued at approximately $1.624 million. Other institutional investors have also increased their stakes in BMNR, which currently holds a "Moderate Buy" consensus …

Shimmick (SHIM) to Post Quarterly Earnings on Monday

Shimmick Corporation (SHIM) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Simmons First National (NASDAQ:SFNC) Sets New 12-Month High - Here's What Happened

Is ARK Trimming Bitmine Immersion Technologies (BMNR) Redefining the Ethereum Treasury Playbook?

ARK Invest recently reduced its holdings in Bitmine Immersion Technologies (BMNR) amid weakening crypto markets, despite previously endorsing its Ethereum treasury strategy as "exponential." This move is significant because Bitmine is considered a leading Ethereum treasury company. The article examines how ARK's decision influences …

OMERS ADMINISTRATION Corp Makes New Investment in Immunic, Inc. $IMUX

OMERS ADMINISTRATION Corp recently invested in Immunic, Inc. (NASDAQ:IMUX) by acquiring 168,300 shares valued at approximately $187,000, representing about 1.24% of the company. Despite a recent earnings miss, analysts maintain a "Buy" consensus rating with an average price target of $47.57. Immunic, a biopharmaceutical …

ETFs Investing in Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh Stocks

This article lists various ETFs that include Immunocore Holdings Plc Shs Sponsored American Depositary Shares Repr 1 Sh stocks in their portfolios. The funds are sorted by market value and provide key financial metrics such as weight, issuer, management style, expense ratio, AUM, price, …

Immunovant (IMVT) Stock Forum and Discussion

This page provides a stock forum and discussion platform for Immunovant (IMVT). It allows investors and interested parties to share insights, opinions, and analysis related to the company's stock performance and future prospects. The forum serves as a community hub for active engagement on …

BWS Financial reiterates Immersion stock buy rating on book value By Investing.com

BWS Financial has reiterated a Buy rating and a $13.50 price target for Immersion (NASDAQ:IMMR) stock. The firm highlights that Immersion is trading below its true book value, especially when considering its significant stake in Barnes & Noble Education (NYSE:BNED). Despite the stock trading …

Carlson Capital L.P. Buys 51,624 Shares of Simmons First National Corporation $SFNC

Carlson Capital L.P. significantly increased its stake in Simmons First National Corporation, purchasing an additional 51,624 shares in Q1, bringing its total to 78,624 shares valued at $1.53 million. Despite missing quarterly earnings estimates, the bank's revenue rose by 16.1% year-over-year, and analysts maintain …

Immutep (NASDAQ: IMMP) ends lung trial, extends cash runway

Immutep Limited (NASDAQ: IMMP) reported mixed Q4 FY26 results, discontinuing its Phase III TACTI-004 lung cancer trial due to futility but showing positive progress in other programs like INSIGHT-003 and IMP761. The company maintains strong liquidity with A$68.87 million in cash and cash equivalents, …

ImmunityBio (IBRX) Could Be 45% Undervalued On UAE ANKTIVA Approval

ImmunityBio (IBRX) has received marketing authorization for ANKTIVA in the UAE for two cancer indications, expanding its global footprint. Despite a recent share price pullback, the company is considered 45% undervalued, with a fair value of $13 compared to its last close of $7.17. …

Price to earnings forward of Immunome, Inc. – NASDAQ:IMNM

This article provides a brief overview of Immunome, Inc. (NASDAQ: IMNM) financials, specifically focusing on its forward price-to-earnings ratio. The content appears to be a stub or a section of a larger financial data page on TradingView, indicating that the detailed financial figures for …

Scinai Immunotherapeutics Ltd (SCNI) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Scinai Immunotherapeutics Ltd (SCNI), noting its current valuation score of 7.40, ranking 176 out of 385 in its industry. It highlights the company's P/E ratio of -0.08, which is significantly below its recent high and above its …

XS207910589 Bond Profile — Key Metrics

This article provides key metrics for the Zimmer Biomet Holdings, Inc. bond with ISIN XS207910589. It details the bond's coupon rate, issue and maturity dates, outstanding amount, face value, and minimum denomination. The company, Zimmer Biomet Holdings, Inc., is described as a designer, manufacturer, …

Immunovant (IMVT.US) will release its earnings report before the market opens on August 6.

Immunovant (IMVT.US) is scheduled to release its earnings report before the market opens on August 6. This announcement provides key information for investors and stakeholders anticipating the company's financial performance.

Immunome Inc (IMNM) Financial Health: Profitability & Balance Sheet Analysis

The article analyzes the financial health of Immunome Inc (IMNM), noting its robust financial status with a score of 7.15 out of 10, ranking 137th in the Biotechnology & Medical Research industry. Despite this, the company exhibits low operating efficiency, with recent quarterly revenue …

IMTX|Immatics NV|Price:8.660|Chg%:-0.540

This article provides an in-depth analysis of Immatics NV (IMTX) stock, including real-time quotes, key financial figures, and market trends. It highlights the company's strong fundamentals, high growth potential, and "Strong Buy" analyst ratings with significant upside potential. The report also details Immatics NV's …